Interleukin (IL-1)α and IL-1β are important mediators of inflammation. The binding of IL-1 to interleukin-1 receptor (IL-1R) type 1 is the initial step in IL-1 signal transduction and therefore is a tempting target for antiinflammatory therapeutics. To advance our understanding of IL-1R1 binding interactions, we have determined the structure of the extracellular domains of IL-1R1 bound to a 21-amino acid IL-1 antagonist peptide at 3.0-Å resolution. The antagonist peptide binds to the domain 1/2 junction of the receptor, which is a conserved binding site for IL-1β and IL-1 receptor antagonist (IL-1ra). This co-crystal structure also reveals that considerable flexibility is present in IL-1R1 because the carboxyl-terminal domain of the receptor is rotated almost 170°relative to the first two domains of the receptor compared with the previously solved IL-1R1 ligand structures. The structure shows an unexpected binding mode for the peptide and may contribute to the design of smaller IL-1R antagonists.
CITATION STYLE
Vigers, G. P. A., Dripps, D. J., Edwards, C. K., & Brandhuber, B. J. (2000). X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1. Journal of Biological Chemistry, 275(47), 36927–36933. https://doi.org/10.1074/jbc.M006071200
Mendeley helps you to discover research relevant for your work.